{"transactions":[{"id":2552655,"issuer":{"id":126356,"kind":"organization","name":"Clarus Therapeutics Holdings, Inc.","symbol":"CRXT"},"owners":[{"id":135031,"kind":"organization","name":"H.I.G. Ventures - Clarus, LLC","position":1,"cik":"0001512060","reported_name":"H.I.G. Ventures - Clarus, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135032,"kind":"organization","name":"H.I.G. Bio-Clarus II, L.P.","position":2,"cik":"0001885010","reported_name":"H.I.G. Bio-Clarus II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135033,"kind":"organization","name":"H.I.G. Bio-Clarus I, L.P.","position":3,"cik":"0001884997","reported_name":"H.I.G. Bio-Clarus I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":128784,"kind":"organization","name":"H.I.G.-GPII, Inc.","position":4,"cik":"0001788482","reported_name":"H.I.G.-GPII, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90453,"kind":"person","name":"TAMER ANTHONY","position":5,"cik":"0001050045","reported_name":"TAMER ANTHONY","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90452,"kind":"person","name":"MNAYMNEH SAMI","position":6,"cik":"0001050046","reported_name":"MNAYMNEH SAMI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-04T16:09:50.000Z","date":"2021-09-09","kind":"grant","acquired":true,"shares":2470756,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Received pursuant to the Agreement and Plan of Merger, dated as of April 27, 2021 by and among Blue Water Acquisition Corp. (n/k/a Clarus Therapeutics Holdings, Inc.) (the \"Issuer\"), Blue Water Merger Sub Corp. and Clarus Therapeutics, Inc. (\"Legacy Clarus\") (the \"Merger Agreement\") pursuant to which, through a merger, Legacy Clarus became a direct, wholly-owned subsidiary of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares reported are held of record by H.I.G. Bio -- Clarus II, L.P (\"Clarus II\"). H.I.G. GP is the general partner of Clarus II and has sole voting and investment control over the shares owned by Clarus II. Mr. Tamer and Mr. Mnaymneh are the sole shareholders of H.I.G. GP and may be deemed to share beneficial ownership of the shares held by Clarus II. Each of Mr. Tamer and Mr. Mnaymneh disclaims beneficial ownership of the shares reported herein except to the extent of their pecuniary interest, if any."}],"balance_after":2470756,"source":{"system":"sec-edgar","filing":"0001013762-21-000025","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1050045/000101376221000025/ownership.xml","form_type":"4"}},{"id":2552654,"issuer":{"id":126356,"kind":"organization","name":"Clarus Therapeutics Holdings, Inc.","symbol":"CRXT"},"owners":[{"id":135031,"kind":"organization","name":"H.I.G. Ventures - Clarus, LLC","position":1,"cik":"0001512060","reported_name":"H.I.G. Ventures - Clarus, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135032,"kind":"organization","name":"H.I.G. Bio-Clarus II, L.P.","position":2,"cik":"0001885010","reported_name":"H.I.G. Bio-Clarus II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135033,"kind":"organization","name":"H.I.G. Bio-Clarus I, L.P.","position":3,"cik":"0001884997","reported_name":"H.I.G. Bio-Clarus I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":128784,"kind":"organization","name":"H.I.G.-GPII, Inc.","position":4,"cik":"0001788482","reported_name":"H.I.G.-GPII, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90453,"kind":"person","name":"TAMER ANTHONY","position":5,"cik":"0001050045","reported_name":"TAMER ANTHONY","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90452,"kind":"person","name":"MNAYMNEH SAMI","position":6,"cik":"0001050046","reported_name":"MNAYMNEH SAMI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-04T16:09:50.000Z","date":"2021-09-09","kind":"grant","acquired":true,"shares":2731094,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Received pursuant to the Agreement and Plan of Merger, dated as of April 27, 2021 by and among Blue Water Acquisition Corp. (n/k/a Clarus Therapeutics Holdings, Inc.) (the \"Issuer\"), Blue Water Merger Sub Corp. and Clarus Therapeutics, Inc. (\"Legacy Clarus\") (the \"Merger Agreement\") pursuant to which, through a merger, Legacy Clarus became a direct, wholly-owned subsidiary of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares reported are held of record by H.I.G. Ventures - Clarus, LLC (\"H.I.G. Ventures\"). H.I.G. GP is the manager of H.I.G. Ventures and has sole voting and investment control over the shares owned by H.I.G. Ventures. Mr. Tamer and Mr. Mnaymneh are the sole shareholders of H.I.G. GP and may be deemed to share beneficial ownership of the shares held by H.I.G. Ventures. Each of Mr. Tamer and Mr. Mnaymneh disclaims beneficial ownership of the shares reported herein except to the extent of their pecuniary interest, if any."}],"balance_after":2731094,"source":{"system":"sec-edgar","filing":"0001013762-21-000025","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1050045/000101376221000025/ownership.xml","form_type":"4"}},{"id":2552653,"issuer":{"id":126356,"kind":"organization","name":"Clarus Therapeutics Holdings, Inc.","symbol":"CRXT"},"owners":[{"id":135031,"kind":"organization","name":"H.I.G. Ventures - Clarus, LLC","position":1,"cik":"0001512060","reported_name":"H.I.G. Ventures - Clarus, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135032,"kind":"organization","name":"H.I.G. Bio-Clarus II, L.P.","position":2,"cik":"0001885010","reported_name":"H.I.G. Bio-Clarus II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135033,"kind":"organization","name":"H.I.G. Bio-Clarus I, L.P.","position":3,"cik":"0001884997","reported_name":"H.I.G. Bio-Clarus I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":128784,"kind":"organization","name":"H.I.G.-GPII, Inc.","position":4,"cik":"0001788482","reported_name":"H.I.G.-GPII, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90453,"kind":"person","name":"TAMER ANTHONY","position":5,"cik":"0001050045","reported_name":"TAMER ANTHONY","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90452,"kind":"person","name":"MNAYMNEH SAMI","position":6,"cik":"0001050046","reported_name":"MNAYMNEH SAMI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-04T16:09:50.000Z","date":"2021-09-09","kind":"grant","acquired":true,"shares":490531,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Received pursuant to the Agreement and Plan of Merger, dated as of April 27, 2021 by and among Blue Water Acquisition Corp. (n/k/a Clarus Therapeutics Holdings, Inc.) (the \"Issuer\"), Blue Water Merger Sub Corp. and Clarus Therapeutics, Inc. (\"Legacy Clarus\") (the \"Merger Agreement\") pursuant to which, through a merger, Legacy Clarus became a direct, wholly-owned subsidiary of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares reported are held of record by H.I.G. Bio -- Clarus I, L.P (\"Clarus I\"). H.I.G.-GPII, Inc. (\"H.I.G. GP\") is the general partner of Clarus I and has sole voting and investment control over the shares owned by Clarus I. Anthony Tamer and Sami Mnaymneh are the sole shareholders of H.I.G. GP and may be deemed to share beneficial ownership of the shares held by Clarus I. Each of Mr. Tamer and Mr. Mnaymneh disclaims beneficial ownership of the shares reported herein except to the extent of their pecuniary interest, if any."}],"balance_after":490531,"source":{"system":"sec-edgar","filing":"0001013762-21-000025","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1050045/000101376221000025/ownership.xml","form_type":"4"}},{"id":3408314,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":154827,"kind":"organization","name":"H.I.G. Bio-Exagen, L.P.","position":1,"cik":"0001788396","reported_name":"H.I.G. Bio-Exagen, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":128784,"kind":"organization","name":"H.I.G.-GPII, Inc.","position":2,"cik":"0001788482","reported_name":"H.I.G.-GPII, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90453,"kind":"person","name":"TAMER ANTHONY","position":3,"cik":"0001050045","reported_name":"TAMER ANTHONY","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90452,"kind":"person","name":"MNAYMNEH SAMI","position":4,"cik":"0001050046","reported_name":"MNAYMNEH SAMI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series H Redeemable Convertible Preferred Stock","published_at":"2019-09-23T21:43:23.000Z","date":"2019-09-23","kind":"exercise","acquired":false,"shares":233446519,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series H Redeemable Convertible Preferred Stock (\"Series H\") is convertible into the Issuer's Common Stock on a 183.635-for-one basis at the holder's election and has no expiration date. The Series H automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series H Redeemable Convertible Preferred Stock (\"Series H\") is convertible into the Issuer's Common Stock on a 183.635-for-one basis at the holder's election and has no expiration date. The Series H automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series H Redeemable Convertible Preferred Stock (\"Series H\") is convertible into the Issuer's Common Stock on a 183.635-for-one basis at the holder's election and has no expiration date. The Series H automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series H Redeemable Convertible Preferred Stock (\"Series H\") is convertible into the Issuer's Common Stock on a 183.635-for-one basis at the holder's election and has no expiration date. The Series H automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares reported on this form are held of record by H.I.G. Bio-Exagen, L.P. (\"H.I.G.\"). H.I.G.-GPII, Inc. (\"H.I.G. GP\") is the general partner of H.I.G. and has sole voting and investment control over the shares owned by H.I.G. Anthony Tamer and Sami Mnaymneh are the sole shareholders of H.I.G. GP and may be deemed to share beneficial ownership of the shares held by H.I.G. Bio-Exagen, L.P. Each of Mr. Tamer and Mr. Mnaymneh disclaims beneficial ownership of the shares reported herein except to the extent of their pecuniary interest, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1271252},"source":{"system":"sec-edgar","filing":"0000899243-19-024078","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1050045/000089924319024078/doc4.xml","form_type":"4"}},{"id":3408313,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":154827,"kind":"organization","name":"H.I.G. Bio-Exagen, L.P.","position":1,"cik":"0001788396","reported_name":"H.I.G. Bio-Exagen, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":128784,"kind":"organization","name":"H.I.G.-GPII, Inc.","position":2,"cik":"0001788482","reported_name":"H.I.G.-GPII, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90453,"kind":"person","name":"TAMER ANTHONY","position":3,"cik":"0001050045","reported_name":"TAMER ANTHONY","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90452,"kind":"person","name":"MNAYMNEH SAMI","position":4,"cik":"0001050046","reported_name":"MNAYMNEH SAMI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-23T21:43:23.000Z","date":"2019-09-23","kind":"purchase","acquired":true,"shares":425000,"price":14,"value":5950000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares reported on this form are held of record by H.I.G. Bio-Exagen, L.P. (\"H.I.G.\"). H.I.G.-GPII, Inc. (\"H.I.G. GP\") is the general partner of H.I.G. and has sole voting and investment control over the shares owned by H.I.G. Anthony Tamer and Sami Mnaymneh are the sole shareholders of H.I.G. GP and may be deemed to share beneficial ownership of the shares held by H.I.G. Bio-Exagen, L.P. Each of Mr. Tamer and Mr. Mnaymneh disclaims beneficial ownership of the shares reported herein except to the extent of their pecuniary interest, if any."}],"balance_after":1696252,"source":{"system":"sec-edgar","filing":"0000899243-19-024078","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1050045/000089924319024078/doc4.xml","form_type":"4"}},{"id":3408312,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":154827,"kind":"organization","name":"H.I.G. Bio-Exagen, L.P.","position":1,"cik":"0001788396","reported_name":"H.I.G. Bio-Exagen, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":128784,"kind":"organization","name":"H.I.G.-GPII, Inc.","position":2,"cik":"0001788482","reported_name":"H.I.G.-GPII, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90453,"kind":"person","name":"TAMER ANTHONY","position":3,"cik":"0001050045","reported_name":"TAMER ANTHONY","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90452,"kind":"person","name":"MNAYMNEH SAMI","position":4,"cik":"0001050046","reported_name":"MNAYMNEH SAMI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-23T21:43:23.000Z","date":"2019-09-23","kind":"exercise","acquired":true,"shares":1271252,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares reported on this form are held of record by H.I.G. Bio-Exagen, L.P. (\"H.I.G.\"). H.I.G.-GPII, Inc. (\"H.I.G. GP\") is the general partner of H.I.G. and has sole voting and investment control over the shares owned by H.I.G. Anthony Tamer and Sami Mnaymneh are the sole shareholders of H.I.G. GP and may be deemed to share beneficial ownership of the shares held by H.I.G. Bio-Exagen, L.P. Each of Mr. Tamer and Mr. Mnaymneh disclaims beneficial ownership of the shares reported herein except to the extent of their pecuniary interest, if any."}],"balance_after":1271252,"source":{"system":"sec-edgar","filing":"0000899243-19-024078","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1050045/000089924319024078/doc4.xml","form_type":"4"}}]}